Written by a leading expert on Aspirin-related research, this is the most comprehensive treatise on the pharmacological effects and clinical applications of one of the most successful drugs ever.
The text is written with a wide audience in mind, and to be readily understandable for clinicians, pharmacists, biomedical researchers and pharmacologists alike.
This second, completely revised edition contains the latest results of clinical and pharmacological research on Acetylsalicylic acid, addressing the multiple pharmacological properties of this famous drug with a balanced view on their translation into clinical practice, including prevention from cardiovascular diseases and colorectal cancer.

Karsten Schror is Professor of Pharmacology and retired Chairman of the Department of Pharmacology and Clinical Pharmacology at the Heinrich-Heine-University in Dusseldorf, Germany. He obtained his M.D. at Martin-Luther-University Halle-Wittenberg (Germany) and carried out postdoctoral studies at the Universities of Halle, Mainz, Koln, the Wellcome Research Laboratories in Beckenham (UK) and the Jefferson Medical College, Philadelphia (USA). He held guest professorships at the Medical University of South Carolina at Charleston (USA) and the Department of Internal Medicine, Division of Hematology, University of Texas Medical Center, Houston (USA). Karsten Schror is member of the German National Academy of Science (Leopoldina) and was President of the German Society for Pharmacology from 2005 to 2010. He has published extensively in the area of aspirin and prostaglandin research with focus on platelet functions and the clotting system and serves on several national and international review panels and advisory committees on thrombosis research, colorectal cancer and drug development.